CAR T, immunotherapy bring new hope for multiple myeloma patients
PHILADELPHIA - Two investigational immunotherapy approaches, including chimeric antigen receptor (CAR) T cell therapy, have shown encouraging results in the ...
Phase 2 CAR-T study reports significant remission rates at 15-month follow up
Credit: MD Anderson Cancer Center A study involving the recently approved CD19-targeting chimeric antigen receptor (CAR) T cell therapy shows ...
Global CAR T therapy trial shows high rates of durable remission for NHL
PHILADELPHIA - In a pair of clinical trials stretching from Philadelphia to Tokyo, the chimeric antigen receptor (CAR) T cell ...
Landmark CAR-T cancer study published in the New England Journal of Medicine
Credit: Loyola Medicine MAYWOOD, IL - Loyola University Medical Center is the only Chicago center that participated in the pivotal ...
Sequencing offers clues to progression toward multiple myeloma
ATLANTA -- Researchers at Dana-Farber Cancer Institute have carried out the largest genomic analysis of patients with smoldering multiple myeloma ...
Rapid responses, few adverse effects in targeted agent in Phase1 trial in rare blood disorder
ATLANTA - In a Phase 1 trial, patients with an advanced or aggressive form of systemic mastocytosis (AdvSM), a rare ...
Tracking how multiple myeloma evolves by sequencing DNA in the blood
ATLANTA - Although people with multiple myeloma usually respond well to treatment, the blood cancer generally keeps coming back. Following ...
Physical activity data, emojis on Apple Watch correlated with patient-reported outcomes
ATLANTA - In findings presented to the American Society of Hematology, Mayo Clinic researchers found that using emojis instead of ...
Study explores use of checkpoint inhibitors after relapse from donor stem cell transplant
ATLANTA - Immunotherapy agents known as checkpoint inhibitors have shown considerable promise in patients with hematologic cancers who relapse after ...
For leukemia patients, transfusion needs may delay hospice care
Toward the end of life, some leukemia patients depend on blood transfusions to ease their suffering. Unfortunately, the likelihood that ...
Immunotherapy drug nearly eliminates severe acute graft-versus-host disease
Credit: Seattle Children's SEATTLE - Dec. 9, 2017 - Results from a phase 2 clinical trial, presented by Seattle Children's ...
Study results offer another boon for PARP inhibitors in treatment of advanced breast cancer
SAN ANTONIO - Patients with certain advanced hereditary breast cancers may have new treatments options on the horizon, according to ...
For women with genetic risk, bi-annual MRI beats mammograms
Intensive surveillance including a dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) exam every six months was far more effective in detecting ...
Lymph node surgery may raise risk of arm morbidity in younger women
SAN ANTONIO -- Younger breast cancer patients who underwent axillary lymph node dissection were more likely to experience arm swelling ...
Family members without inherited mutation have increased risk of melanoma
In families who carry certain inherited mutations that increase the risk for melanoma, members who do not carry the mutation ...
Molecular beacon signals low oxygen with ultrasound
Credit: Video courtesy of Jefferson Chan, University of Illinois CHAMPAIGN, Ill. -- Areas of hypoxia, or low oxygen in tissue, ...
ERC grant: €2 million for synthetic biology at TU Darmstadt
Darmstadt, December 8, 2017. The European Research Council awards an ERC Consolidator Grant to professor Heinz Koeppl and supports him ...
PARP inhibitor improves progression-free survival in patients with advanced breast cancers and BRCA
Credit: MD Anderson Cancer Center In a randomized, Phase III trial led by researchers at The University of Texas MD ...
ECOG-ACRIN discovers a simple blood test may predict recurrence of breast cancer
A simple blood test that detects tumor cells circulating in the blood shows promise as a new way to predict ...
Including diagnosis related costs, 3-D mammography costs less than digital mammography
SAN ANTONIO - Although digital breast tomosynthesis (DBT), or 3-D mammography, costs more than a digital mammography (DM) screening, it ...
